Search Results for: weekly reads

Weekly reads: Melton leaves Harvard, Fuji, BBC blunder, stem cell niche, more

Senolytics restore the stem cell niche in the brains of mice. Fatt, et al. Stem Cell Reports 2022.

Sometimes a post here on The Niche (named after the stem cell niche) sparks a debate between expert stem cell researchers and often that gives much more depth to a topic. Such was the case with my post this week on where things stand with stem cell therapy for heart disease. It led to a …

Weekly reads: Melton leaves Harvard, Fuji, BBC blunder, stem cell niche, more Read More »

Weekly reads: Google, stem cells & MS, VSELs, ‘hairy’ organoids, MYC

stem cells differentiating into neurons and glia

It’s been quite a ride doing this blog on stem cells and other technologies for more than a dozen years. So far it seems like I’ll keep it going. A large part of the reason is because of people needing good information about our field. Those people include scientists and physicians but also many in …

Weekly reads: Google, stem cells & MS, VSELs, ‘hairy’ organoids, MYC Read More »

Weekly reads: Yale scientist suspended, WA AG sues clinic, new pubs

Dr. Tami Meraglia has been sued by the Washington State AG for selling unproven stem cells.

It’s very challenging to be an academic scientist even under normal circumstances so when a government starts going after researchers for things like supposed irregularities in funding disclosures, it can cause serious problems if not carefully overseen. We’ll start this week’s recommended reads with the feds monitoring such disclosures and even making referrals to the …

Weekly reads: Yale scientist suspended, WA AG sues clinic, new pubs Read More »

Stem cell weekly reads: Jamie Thomson, Lamin B1, CRISPR

james-a.-thomson-214x3001

The big news of the week was a $3.6 million settlement by a stem cell clinic, StemGenex, and one of its doctors in a class-action suit. I covered this StemGenex settlement and so did Michael Hiltzik of the LA Times and Paul Schloesser at Endpoints. I’d say this was good news for the stem cell field …

Stem cell weekly reads: Jamie Thomson, Lamin B1, CRISPR Read More »

Stem cells for MS & other weekly reads: CRISPR, COVID & a bat cave, Huntington’s

Symptoms_of_multiple_sclerosis.svg_

About 1 million people are living with multiple sclerosis in the U.S. alone with millions of other cases around the world so a huge effort has gone into trying to find new approaches to the disease including stem cells for MS. We’ll start our weekly recommended reads by talking about a new paper on MS …

Stem cells for MS & other weekly reads: CRISPR, COVID & a bat cave, Huntington’s Read More »

Weekly reads: possible rare HIV cure, stem cell chicken, FDA commish

HIV infected T cell, HIV cure

The idea of stem cells outright curing diseases is exciting and has powerful appeal, but media need to be careful about using the word cure in headlines and articles as we saw this week related to a possible HIV Cure. HIV cure via stem cells and chemo? The big news of the week was that …

Weekly reads: possible rare HIV cure, stem cell chicken, FDA commish Read More »

Weekly reads: MSC, p53, EuroGCT, fake fish, K27M CAR-T

mesenchymal cells

What exactly is a mesenchymal cell and what does the acronym MSC stand for these days? I took a stab recently at discussing mesenchymal cells and the MSC acronym so check that out. There is a great need for standards on MSCs and the products out there being marketed as MSCs are probably in reality …

Weekly reads: MSC, p53, EuroGCT, fake fish, K27M CAR-T Read More »

Weekly reads: CAR-T cell good news, Califf fight, stem cells on lymph

CAR-T-cell-infographic

Not everything in biomedical science is a ground-breaking discovery or clinical game-changer, but CAR-T cell technology is a combination of both. CAR-T cell good news We have such good news in this new pub on long-term benefits: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells, Nature. Another recent CAR-T cell article, this one in Science, …

Weekly reads: CAR-T cell good news, Califf fight, stem cells on lymph Read More »

Weekly reads: aging, CRISPR delivery, hair, oocytes, paralysis

CRISPR-Model-Jacob-Corn-e1464305007640

The big news of the week was the launch of Altos labs and their ambitious plan to tackle aging through cell therapies. Altos has recruited a large number of top cell biologists away from academia. That team plus top biotech execs and a $3B war chest make Altos one to watch in coming years. I …

Weekly reads: aging, CRISPR delivery, hair, oocytes, paralysis Read More »

Weekly reads: hydra heads, iblastoids, new 8-year grants

Grant writers handbook, grants cartoon

What if you could get 8-year grants to do whatever biomedical research you wanted? This sounds like a dream for many of us in the life sciences, but the first news item this week is all about such a potential new funding approach. The item especially caught my eye as I’m going to be doing …

Weekly reads: hydra heads, iblastoids, new 8-year grants Read More »